Amanda practices in the life sciences group and assists in the drafting and prosecution of U.S. and foreign patent applications primarily in the areas of pharmaceuticals and biotechnology.
Amanda’s doctoral research focused on understanding protein-small molecule interactions with the goal of identifying new, therapeutically relevant pathways. She investigated the impact of acute inhibition of insulin degrading enzyme in the context of type 2 diabetes. She has experience with cell culture, affinity mass spectrometry, biochemical and in vivo mouse techniques.
Amanda has co-authored scientific publications in the Proceedings of the National Academy of Sciences, Chemistry & Biology, the Journal of Immunology, Nature, the Journal of the American Chemical Society, and PLOS ONE.